TAG:
american pathology
Pathology PPM Attempts Public Offering Of Shares
By R. Lewis Dark | From the Volume IV No. 13 – September 15, 1997 Issue
CEO SUMMARY: AmeriPath’s efforts to become a public company make it the most visible management experiment in the pathology world today. Already considered controversial by many pathologists, should AmeriPath successfully pull off its proposed initial public stock offering, it will assu…
How AmeriPath Will Alter Pathology Marketplace
By Robert Michel | From the Volume IV No. 13 – September 15, 1997 Issue
CEO SUMMARY: Few pathologists realize how much impact AmeriPath’s business activities will have upon the profession of pathology. Regardless of AmeriPath’s ultimate success or failure, it will bring about irrevocable change to the pathology industry. As the harbinger of such change, A…
Physician Management Companies Exploding, Will Transform Healthcare
By Robert Michel | From the Volume IV No. 10 – July 14, 1997 Issue
CEO SUMMARY: Consolidation and integration of healthcare services will be the dominant trend during the next five years. It happened to commercial laboratories from 1985-95. Widespread hospital consolidation began around 1990 and continues today. Now consolidation is coming to physicians….
“June 2, 1997 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume IV No. 8 – June 2, 1997 Issue
With commercial laboratories pressing hospital laboratories for joint ventures, a unique selling proposition helps. MDS-AutoLab, Inc. of Canada has a different twist. They will not sell you their automated laboratory equipment. Instead, they offer it on a profit-sharing type of arran…
Success Seems Elusive To Pathology Innovators
By Robert Michel | From the Volume IV No. 6 – April 21, 1997 Issue
CEO SUMMARY: Attempts to organize pathology practice management companies encounter resistance and market impediments. Success requires an astute business plan and a sophisticated management team to convince pathologists to abandon proven practice models and affiliate with regional or nat…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized